It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...

Women prescribed a GLP-1 receptor agonist up to 2 years before conception were less likely to develop hypertensive disorders ...

Obesity is an epidemic in the United States, but more people are shedding pounds with the help of weight loss drugs.

Before you take our quiz on The science of weight-loss drugs, make sure you check out our Periodic Graphic for some helpful hints.

Share on Pinterest Women with diabetes may get the strongest cardiovascular protection from GLP-1 agonists. Image credit: Kathryn Gamble for The Washington Post via Getty Images. Diabetes ...

Glucagon-like peptide-1 receptor agonist medications for weight loss are significantly transforming the field of facial plastic surgery.

Opens in a new tab or window The GLP-1 receptor agonist exenatide failed to meet ... priority in investigator-initiated trials than they do in industry-funded studies, Kalia noted.

as well as consider emerging pharmacological approaches to treating obesity and discuss how these differ from currently available GLP-1 agonists. About Elizabeth Mietlicki-Baase Dr. Elizabeth ...

The rise of GLP-1 agonist weight loss drugs has prompted the supplement industry to launch a bevy of “natural alternatives” to pharmaceutical compounds like Ozempic and Wegovy. But do they actually ...